Cell Line : HS578BST
Cellosaurus Index : CVCL_0807
Cellosaurus ID : HS578BST
CTRP2 Name
: HS578BST
CCLE Name
: HS578BST_BREAST
Cancer Type : breast
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| HS578BST | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| HS578BST | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| HS578BST | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AZD4547 | CTRP2 | 0.5200 | 66.0000 |
|
| HS578BST | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | bafilomycin A1 | CTRP2 | 0.0000 | 0.3300 |
|
| HS578BST | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BI-2536 | CTRP2 | 0.0010 | 0.1300 |
|
| HS578BST | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BMS-195614 | CTRP2 | 0.0020 | 0.2600 |
|
| HS578BST | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| HS578BST | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| HS578BST | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 0.1900 |
|
| HS578BST | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | BRD-K04800985 | CTRP2 | 0.0020 | 67.0000 |
|
| HS578BST | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K13999467 | CTRP2 | 0.0020 | 67.0000 |
|
| HS578BST | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K17060750 | CTRP2 | 0.0020 | 67.0000 |
|
| HS578BST | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| HS578BST | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K29313308 | CTRP2 | 0.5200 | 66.0000 |
|
| HS578BST | BRD-K30748066 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K33199242 | CTRP2 | 0.0020 | 67.0000 |
|
| HS578BST | BRD-K33514849 | CTRP2 | 0.0010 | 34.0000 |
|
| HS578BST | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| HS578BST | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K63431240 | CTRP2 | 0.0009 | 30.0000 |
|
| HS578BST | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| HS578BST | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| HS578BST | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | BRD9876:MK-1775 (4:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 48.0000 |
|
| HS578BST | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| HS578BST | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | CHEMBL1222381 | CTRP2 | 0.0081 | 1.0000 |
|
| HS578BST | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| HS578BST | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | ciclopirox | CTRP2 | 0.0020 | 0.2600 |
|
| HS578BST | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Compound 1541A | CTRP2 | 0.0011 | 0.1400 |
|
| HS578BST | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| HS578BST | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| HS578BST | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | DBeQ | CTRP2 | 0.0020 | 0.2600 |
|
| HS578BST | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| HS578BST | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| HS578BST | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| HS578BST | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| HS578BST | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| HS578BST | GSK-J4 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| HS578BST | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HS578BST | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| HS578BST | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| HS578BST | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | LE-135 | CTRP2 | 0.0020 | 0.2600 |
|
| HS578BST | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | manumycin A | CTRP2 | 0.0009 | 0.1200 |
|
| HS578BST | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Masitinib | CTRP2 | 0.0020 | 0.2600 |
|
| HS578BST | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| HS578BST | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| HS578BST | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| HS578BST | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS578BST | necrostatin-1 | CTRP2 | 0.0160 | 2.1000 |
|
| HS578BST | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| HS578BST | NSC23766 | CTRP2 | 0.0160 | 2.1000 |
|
| HS578BST | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Nutlin-3a | CTRP2 | 0.0045 | 150.0000 |
|
| HS578BST | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Obatoclax Mesylate | CTRP2 | 0.0020 | 0.2600 |
|
| HS578BST | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| HS578BST | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | OSI-027 | CTRP2 | 0.5200 | 66.0000 |
|
| HS578BST | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| HS578BST | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| HS578BST | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.2600 | 33.0000 |
|
| HS578BST | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | PLX-4720 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| HS578BST | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| HS578BST | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Quizartinib | CTRP2 | 0.5200 | 66.0000 |
|
| HS578BST | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| HS578BST | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| HS578BST | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | SB-743921 | CTRP2 | 0.0010 | 0.1300 |
|
| HS578BST | SCH-529074 | CTRP2 | 0.2600 | 33.0000 |
|
| HS578BST | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| HS578BST | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS578BST | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS578BST | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS578BST | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS578BST | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS578BST | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS578BST | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS578BST | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS578BST | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| HS578BST | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS578BST | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| HS578BST | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| HS578BST | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HS578BST | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| HS578BST | SNX-2112 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HS578BST | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | SR8278 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | STF-31 | CTRP2 | 0.0020 | 0.2600 |
|
| HS578BST | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Tamoxifen | CTRP2 | 0.0030 | 0.3900 |
|
| HS578BST | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HS578BST | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| HS578BST | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| HS578BST | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| HS578BST | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| HS578BST | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | VAF-347 | CTRP2 | 0.5200 | 66.0000 |
|
| HS578BST | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| HS578BST | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| HS578BST | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| HS578BST | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | VX-680 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | WZ8040 | CTRP2 | 0.0020 | 0.2600 |
|
| HS578BST | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| HS578BST | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| HS578BST | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| HS578BST | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC